TDP-43 frontotemporal lobar degeneration and autoimmune disease.
about
Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domainsDiagnosis and management of behavioral variant frontotemporal dementiaBiomarkers in dementia: clinical utility and new directionsPrimary progressive aphasia and the evolving neurology of the language networkWhite matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort.Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceProgranulin facilitates conversion and function of regulatory T cells under inflammatory conditions.Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity.The role of PGRN in musculoskeletal development and disease.TDP-43 Inhibits NF-κB Activity by Blocking p65 Nuclear Translocation.Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent mannerFrontotemporal dementia: diagnosis, deficits and managementNetwork-driven plasma proteomics expose molecular changes in the Alzheimer's brain.Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with α7 nicotinic acetylcholine receptor agonistsThe relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer's diseaseAutoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture.Therapy and clinical trials in frontotemporal dementia: past, present, and future.The brain connectivity basis of semantic dementia: a selective review.Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging.Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells.Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.Frontotemporal dementia.Biomarkers of Neurodegeneration in Autoimmune-Mediated EncephalitisClinical, Anatomical, and Pathological Features in the Three Variants of Primary Progressive Aphasia: A ReviewCerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupBiomarkers in frontotemporal dementia
P2860
Q24337327-EBAFFEDB-8F59-40D6-A252-BEED874E1D1CQ27006258-00BB75F8-A10A-4460-B5CC-05869AF67339Q27007086-F10583FA-07AE-4EAB-8A26-9981A18F5982Q27011657-4D5F50B8-2307-4012-95CB-31248E56D6A5Q33676267-916359EF-B53D-4DEA-88EB-305402437DE3Q33719360-3F5FD123-F648-484C-AA2E-50C0118D4D20Q33947639-6DC1FC98-4FD9-476A-901F-770E3AC5A20DQ35418640-A84FBB31-CDE3-4224-B19D-98B70CBAA885Q35541825-5E40FEB9-FCF3-4C45-9A5D-1BFB8B0AA7B9Q35546476-DF714501-F332-45A4-8564-857B9F193DD5Q35842277-DF8B2245-7189-4F43-8023-6F2B51FCAA07Q36595482-D85251EC-EA6A-4B6C-B158-F292D5BFCF72Q36776482-18FAFECD-376F-44AE-9FE3-CEFDF4845BF0Q36836566-0A71EABF-498E-44A7-8E86-07C61D1C093FQ36877434-378EA2B4-61B1-45A8-A563-2345C5439F48Q37054759-2AEF2AB2-6E4D-468D-BF0B-F7ED27A0440EQ37227101-C6796E21-785C-4914-9F08-442D8E4F16FBQ37380290-C7060456-A38F-4018-A284-9EBF2CD36A63Q37566888-ABC90C7D-2298-41F1-9066-B5DED5C5BB66Q38404595-BCA20D24-78CA-436C-85FE-AD90D0C0B053Q38506602-185B66CA-EAE3-488B-8F15-3C97D496834FQ38738414-9356245D-07B1-44A0-9C40-FB40AF9CE4DFQ39454075-BBDAA05D-9EAD-47FE-AF5A-2E0E90FA03CEQ41159026-0F3DF581-6F38-413A-99F6-53FE592A6E97Q43041358-3477BF2A-883C-4667-A00C-DAE26D2CF4B9Q43856158-4C6F1345-EA0B-49BE-A853-4733FB7C9CECQ47218394-2A50D149-93C6-4475-AAD7-743293476D76Q47623958-0B67446C-E897-430F-8930-3033B886D999Q50538464-08E97A4E-CDDF-4F82-A763-093203A31AE7Q53268278-6BE50DF3-FB21-47E4-A9F3-9D8A7DC82A1AQ57072879-3206D77D-1697-40B3-BA00-FB666A820493Q57168245-A67A741D-C89E-4081-BBFA-16E4B4669C87Q57168893-AC7E2A08-6789-47A1-A978-B6E93FAAC350Q57911950-8C945B6F-1464-40A2-B0D6-05AD66DEA17E
P2860
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@en
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@nl
type
label
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@en
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@nl
prefLabel
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@en
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@nl
P2093
P2860
P50
P356
P1476
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
@en
P2093
Anna Karydas
Baber K Khan
Clare M Cleveland
Daniel H Geschwind
Giovanni Coppola
Howard J Rosen
Joel H Kramer
Kristin A Heggeli
Lea T Grinberg
Leonel T Takada
P2860
P304
P356
10.1136/JNNP-2012-304644
P407
P50
P577
2013-03-30T00:00:00Z